Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.

MLA

Cagney, Daniel N., et al. “Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation.” Radiotherapy & Oncology, vol. 126, no. 3, Mar. 2018, pp. 511–18. EBSCOhost, https://doi.org/10.1016/j.radonc.2018.01.005.

APA

Cagney, D. N., Martin, A. M., Catalano, P. J., Reitman, Z. J., Mezochow, G. A., Lee, E. Q., Wen, P. Y., Weiss, S. E., Brown, P. D., Ahluwalia, M. S., Arvold, N. D., Tanguturi, S. K., Haas-Kogan, D. A., Alexander, B. M., Redig, A. J., & Aizer, A. A. (2018). Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. Radiotherapy & Oncology, 126(3), 511–518. https://doi.org/10.1016/j.radonc.2018.01.005

Chicago

Cagney, Daniel N., Allison M. Martin, Paul J. Catalano, Zachary J. Reitman, Gabrielle A. Mezochow, Eudocia Q. Lee, Patrick Y. Wen, et al. 2018. “Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation.” Radiotherapy & Oncology 126 (3): 511–18. doi:10.1016/j.radonc.2018.01.005.